A Cutting-Edge Cancer Treatment Is Under FDA Investigation—for Cancer Risk

CAR-T cell therapy harnesses the immune system to attack blood cancers. Six years after approving the first treatment, the FDA is investigating whether it can give rise to secondary cancers. Read this story here. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Episode metadata supplied by the publisher feed · Published Nov 30, 2023

Embed this episode

Attribution link and audio player

NOW PLAYING

A Cutting-Edge Cancer Treatment Is Under FDA Investigation—for Cancer Risk

0:00 9:13

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Science, Spoken?

This episode is 9 minutes long.

When was this Science, Spoken episode published?

This episode was published on November 30, 2023.

Can I download this Science, Spoken episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!